Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

Recruiting Observational Study
Severe Aortic Stenosis Cardiogenic Shock Cardiogenic Shock, ECMO Trans-catheter Aortic Valve Implantation
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Atlantic Health System · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the feasibility, effectiveness, and safety of pre-emptive left atrial veno-arterial extracorporeal membrane oxygenation (LAVA-ECMO) in patients undergoing complex and high-risk transcatheter aortic valve replacement (TAVR). These patients include adults with severe aortic stenosis who are hemodynamically unstable or at risk of instability due to anato…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Patients are required to have either a Class III hemodynamic status OR type B or type C anatomical complexity with Class II (at risk) hemodynamics (Figure 2). * Hemodynamic Criteria * Major Criteria (Class III) * Systolic blood pressure \<90 mmHg or MAP\<60 mmHg …
Contacts

Gennaro Giustino, MD

9739718858

Gennaro.Giustino@atlantichealth.org

CONTACT

Pedro Villablanca, MD

pvillab1@hfhs.org

CONTACT